A single-center case-control study enrolling 174 subjects found that serum Nrg4 levels were significantly decreased in patients with NAFLD compared to healthy controls and were markedly associated with NAFLD, although not with the severity of NAFLD as assessed by ultrasound (Dai et al., 2015). This evidence concerns the gene NRG4 and metabolic dysfunction-associated steatotic liver disease.